Constellium SE
NYSE:CSTMAluminum
+$0.32 today
- Market cap
- $2.88B
- Beta
- 1.54
- P/E (TTM)
- 10.7
- EPS (TTM)
- $3.17
Volume 1.46M
Average 2.27M
CSTM Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Constellium SENYSE: CSTM
Accounts Payables · Q3 FY2026 · quarter ended Sep 2026
Accounts payables grows 2409.0% year over year
Q3 FY2026 accounts payables of $480M (cash outflow) rose 2409.0% year over year. Over 3 fiscal years it compounded at +57.4% a year.
Context
- Accounts payables amounted to 2.0% of revenue in FY2025, up 1.4 pp from a year earlier.
- Accounts payables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
Mixed currencies · from the cash flow
- Latest · FY2025
- 167.95M USD
- Year-over-year change
- —
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 167.95M | — |
| FY2024 | 2024-12-31 | (38.63M) | +81.2% |
| FY2023 | 2023-12-31 | (206M) | -578.1% |
| FY2022 | 2022-12-31 | 43.09M | -89.1% |
| FY2021 | 2021-12-31 | 396M | — |
Accounts Payables vs competitors
How CSTM compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
- Accounts payables amounts to 0.6% of revenue for CSTM, versus a peer median of 1.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $198.4M USD | +354.0% | — | 4.8% | |
| LTM Mar 2026 | R$123.46M BRL | -87.1% | — | 0.3% | |
| LTM Jun 2026 | $119M USD | +988.1% | — | 1.8% | |
| FY2026 | ZAR 105.41M ZAR | -8246.1% | — | 1.0% | |
| LTM Jul 2026 | $74.9M USD | +705.5% | +37.6% | 3.6% | |
| LTM Sep 2026 | $60.8M USD | +208.8% | — | 2.0% | |
| LTM Sep 2026 | $57.89M USD | — | +57.4% | 0.6% | |
| LTM Sep 2026 | $37.56M USD | +190.6% | -3.2% | 0.6% | |
| LTM Jun 2026 | $23.54M USD | — | — | 2.3% | |
| LTM Jun 2026 | $22.42M USD | +492.4% | — | 1.9% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding CSTM) | — | +281.4% | +17.2% | 1.8% | |
Competitors are the stored peer set for CSTM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 · EUR | FY2022 Dec 2022 · EUR | FY2023 Dec 2023 · EUR | FY2024 Dec 2024 · EUR | FY2025 Dec 2025 · USD |
|---|---|---|---|---|---|
| Net Income | 296.64M | 316.34M | 152M | 54.08M | 272.92M |
| Depreciation & Amortization | 302.3M | 287M | 275.07M | 293.57M | 330M |
| Deferred Income Tax | 55M | (133.47M) | 75M | 72.43M | 0 |
| Stock-Based Compensation | 15M | 0 | 0 | 0 | 0 |
| Change in Working Capital | (261M) | (90.38M) | (119M) | (181.55M) | (222.93M) |
| Accounts Receivables | (227M) | 162.9M | (37M) | (48.29M) | (202.94M) |
| Inventory | (435M) | (253.28M) | 202M | (23.18M) | (148.95M) |
| Accounts Payables | 396M | 43.09M | (206M) | (38.63M) | 167.95M |
| Other Working Capital | 5M | (43.09M) | (78M) | (71.46M) | (38.99M) |
| Other Non-Cash Items | (50.94M) | 93.45M | 48.93M | 52.15M | 108.87M |
| Operating Cash Flow | 357M | 472.94M | 432M | 290.68M | 488.85M |
| Capital Expenditures | (232M) | (286.92M) | (366M) | (398.83M) | (329.9M) |
| Acquisitions (Net) | 9.36M | 2.1M | 49M | 9.66M | 11M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 1.64M | (1.05M) | 98M | 82.08M | 3M |
| Investing Cash Flow | (221M) | (285.87M) | (219M) | (307.09M) | (315.9M) |
| Debt Repayment | (377M) | (126.12M) | (166M) | 13.52M | (60.98M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | (76.29M) | (114.96M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (58M) | (42.04M) | (8M) | 8.69M | (31.99M) |
| Financing Cash Flow | (435M) | (168.16M) | (174M) | (54.08M) | (207.94M) |
| Effect of Forex Changes | 7M | (8.92M) | 6.84M | (8.69M) | 14M |
| Net Change in Cash | (292M) | 10M | 45.84M | (79.19M) | (20.99M) |
| Free Cash Flow | 125M | 186.02M | 66M | (108.16M) | 158.95M |
Constellium SE
NYSE:CSTM
Intrinsic Alpha fair value
Locked
Current Price
$21.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.